» Articles » PMID: 16790042

An ELISA-based Procedure for Assaying Proteins in Digests of Human Leukocytes and Cell Lines, Using Specifically Selected Peptides and Appropriate Antibodies

Overview
Journal Proteome Sci
Publisher Biomed Central
Date 2006 Jun 23
PMID 16790042
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We describe the application of an ELISA-based assay (the Peptidomatrix) that can be used to simultaneously identify and quantitate a number of proteins in biological samples. The biological sample (blood component, biopsy, culture or other) is first lysed to release all the proteins, without any additional separation. The denatured proteins in the sample are then digested in bulk with the desired proteolytic enzyme(s). The peptides in the digest are then assayed by appropriate antibodies, using a competition ELISA protocol.

Results: As an example of its use, the present paper applies the Peptidomatrix to the assay of four membrane proteins MDR1 (P-glycoprotein or ABCB1), MRP1 (ABCC1), BCRP/MXR (ABCG2) and the alpha subunit of the Na, K_ATPase (ATP1A1), present in a number of cell lines and in human lymphocytes. We show that we can detect and quantitate these proteins, using a series of peptide-antibody pairs, and that we can differentiate between cell lines or cell preparations that express the target proteins and those that do not.

Conclusion: We have devised a simple, ELISA-based proteomics assay that enables the quantitation of designated proteins in a cell or tissue sample, and that can be used in any laboratory, with minimal specialized equipment.

Citing Articles

Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins.

Elsayed Y, Kuhl T, Imhof D J Pept Sci. 2025; 31(3):e70001.

PMID: 39921384 PMC: 11806371. DOI: 10.1002/psc.70001.


Trends and Applications of Omics Technologies to Functional Characterisation of Enzymes and Protein Metabolites Produced by Fungi.

Ijoma G, Heri S, Matambo T, Tekere M J Fungi (Basel). 2021; 7(9).

PMID: 34575737 PMC: 8464691. DOI: 10.3390/jof7090700.

References
1.
Marbeuf-Gueye C, Ettori D, Priebe W, Kozlowski H, Garnier-Suillerot A . Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein. Biochim Biophys Acta. 1999; 1450(3):374-84. DOI: 10.1016/s0167-4889(99)00060-9. View

2.
Robey R, Bakke S, Stein W, Meadows B, Litman T, Patil S . Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833. Blood. 1998; 93(1):306-14. View

3.
Bichsel V, Liotta L, Petricoin 3rd E . Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J. 2001; 7(1):69-78. View

4.
Miklos G, Maleszka R . Integrating molecular medicine with functional proteomics: realities and expectations. Proteomics. 2001; 1(1):30-41. DOI: 10.1002/1615-9861(200101)1:1<30::AID-PROT30>3.0.CO;2-X. View

5.
Wulfkuhle J, McLean K, Paweletz C, Sgroi D, Trock B, Steeg P . New approaches to proteomic analysis of breast cancer. Proteomics. 2001; 1(10):1205-15. DOI: 10.1002/1615-9861(200110)1:10<1205::AID-PROT1205>3.0.CO;2-X. View